Literature DB >> 8358536

Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration.

D G MacGregor1, T W Stone.   

Abstract

1. Binding of the peripheral benzodiazepine receptor ligand, [3H]-PK 11195, to rat hippocampal membranes has been used to quantify the reactive gliosis resulting from neuronal death induced by intraperitoneally administered kainic acid. 2. Intraperitoneal administration of kainic acid (10 mg kg-1) caused a 350-500% increase in [3H]-PK 11195 binding measured in rat hippocampal P2 membranes 7 days later. Co-treatment with the adenosine derivative R-phenylisopropyladenosine (R-PIA) (100, 25 or 10 micrograms kg-1, i.p.) abolished this elevation. The protective action of R-PIA could itself be abolished by co-treatment with 8-phenyltheophylline (1 mg kg-1). 3. Body temperatures were recorded in the antagonist experiments and no significant changes were recorded, suggesting that the protective action of R-PIA was not mediated by hypothermia. 4. Since systemic kainic acid-induced neurotoxicity has been claimed as a good model of neuronal death in temporal lobe epilepsy, the results suggest that the systemic administration of purines in low doses may provide protection against certain neurodegenerative insults.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358536      PMCID: PMC2175678          DOI: 10.1111/j.1476-5381.1993.tb13572.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  52 in total

1.  Systemic injection of kainic acid: gliosis in olfactory and limbic brain regions quantified with [3H]PK 11195 binding autoradiography.

Authors:  C A Altar; M Baudry
Journal:  Exp Neurol       Date:  1990-09       Impact factor: 5.330

2.  Increase in omega 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-alpha and lipopolysaccharide.

Authors:  F Bourdiol; S Toulmond; A Serrano; J Benavides; B Scatton
Journal:  Brain Res       Date:  1991-03-15       Impact factor: 3.252

3.  Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion.

Authors:  S P Butcher; R Bullock; D I Graham; J McCulloch
Journal:  Stroke       Date:  1990-12       Impact factor: 7.914

4.  Mild hypothermia prevents ischemic injury in gerbil hippocampus.

Authors:  F A Welsh; R E Sims; V A Harris
Journal:  J Cereb Blood Flow Metab       Date:  1990-07       Impact factor: 6.200

5.  In vivo binding to peripheral benzodiazepine binding sites in lesioned rat brain: comparison between [3H]PK11195 and [18F]PK14105 as markers for neuronal damage.

Authors:  G W Price; R G Ahier; S P Hume; R Myers; L Manjil; J E Cremer; S K Luthra; C Pascali; V Pike; R S Frackowiak
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

6.  Postischemic hypothermia fails to reduce ischemic injury in gerbil hippocampus.

Authors:  F A Welsh; V A Harris
Journal:  J Cereb Blood Flow Metab       Date:  1991-07       Impact factor: 6.200

7.  MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats.

Authors:  J W McDonald; F S Silverstein; M V Johnston
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

8.  The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration.

Authors:  P B Andersson; V H Perry; S Gordon
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

9.  A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N-methyl-D-aspartate or quisqualate, and the effects on toxicity of 2-amino-5-phosphonovaleric acid and kynurenic acid in the rat.

Authors:  P Winn; T W Stone; M Latimer; M H Hastings; A J Clark
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

10.  Release of Ca2+ from heart and kidney mitochondria by peripheral-type benzodiazepine receptor ligands.

Authors:  R Moreno-Sánchez; C Bravo; J Gutiérrez; A H Newman; P K Chiang
Journal:  Int J Biochem       Date:  1991
View more
  5 in total

1.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

2.  Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists.

Authors:  W M H Behan; T W Stone
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  The adenosine A1 receptor agonist WAG 994 suppresses acute kainic acid-induced status epilepticus in vivo.

Authors:  Zin-Juan Klaft; Lina M Duerrwald; Zoltan Gerevich; Chris G Dulla
Journal:  Neuropharmacology       Date:  2020-06-29       Impact factor: 5.250

Review 4.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

5.  Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.

Authors:  D G MacGregor; W J Miller; T W Stone
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.